Advertisement
Canada markets close in 1 hour 47 minutes
  • S&P/TSX

    22,031.10
    +159.14 (+0.73%)
     
  • S&P 500

    5,071.97
    +61.37 (+1.22%)
     
  • DOW

    38,494.23
    +254.25 (+0.66%)
     
  • CAD/USD

    0.7320
    +0.0019 (+0.26%)
     
  • CRUDE OIL

    83.25
    +1.35 (+1.65%)
     
  • Bitcoin CAD

    91,242.92
    +121.20 (+0.13%)
     
  • CMC Crypto 200

    1,436.85
    +22.09 (+1.56%)
     
  • GOLD FUTURES

    2,341.10
    -5.30 (-0.23%)
     
  • RUSSELL 2000

    2,008.73
    +41.26 (+2.10%)
     
  • 10-Yr Bond

    4.5900
    -0.0330 (-0.71%)
     
  • NASDAQ

    15,710.33
    +259.02 (+1.68%)
     
  • VOLATILITY

    15.94
    -1.00 (-5.91%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     

How Canopy Growth Is Focusing on International Markets

How Canopy Growth Is Focusing on International Markets

While Canada has become the primary focus market for cannabis producers (HMMJ) such as Canopy Growth (WEED)(CGC), Aurora Cannabis (ACB), Aphria (APHQF), and MedReleaf (MEDFF), international markets have also gained significant traction. For example, in the fourth quarter, Germany accounted for ~10% of Canopy Growth’s medical cannabis sales, and German sales grew 120% YoY (year-over-year), according to Canopy. This momentum helped the company get a higher price per gram sold. In the fourth quarter, Canopy Growth’s price per gram sold rose YoY to an average of 8.40 Canadian dollars from 8. ...